Source: MarketersMedia

Press Release: Edgewell Personal Care : Earnings Review and Free Research Report: Herbalife's Q1 Results Beat Forecasts

Research Desk Line-up: Edgewell Personal Care Post Earnings CoverageLONDON, UK / ACCESSWIRE / August 17, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Herbalife Ltd (NYSE: HLF), which can be viewed by registering at, following the Company's disclosure of its financial results on August 01, 2017, for the second quarter fiscal 2017 (Q2 FY17). The Los Angeles, California-based Company's adjusted diluted EPS improved on a year-over-year basis, outperforming market consensus estimates. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at: more of our free earnings reports coverage from other constituents of the Personal Products industry. Pro-TD has currently selected Edgewell Personal Care Company (NYSE: EPC) for due-diligence and potential coverage as the Company announced on August 08, 2017, its financial results for Q3 FY17 which ended on June 30, 2017. Register for a free membership today, and be among the early birds that get access to our report on Edgewell Personal Care when we publish it.At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on HLF; also brushing on EPC. With the links below you can directly download the report of your stock of interest free of charge at: ReviewedDuring the quarter ended on June 30, 2017, Herbalife's worldwide net sales fell 5% to $1.15 billion from $1.20 billion recorded at the end of Q2 FY16. However, net sales numbers topped market consensus estimates of $1.10 billion for Q2 FY17. On a constant currency basis, the Company's net sales fell 3% y-o-y. Furthermore, sales volume was down by 8% to 1.36 billion in Q2 FY17.The seller of supplements and weight-loss products reported net income of $137.6 million, or $1.61 per diluted share, in Q2 FY17 versus net loss of $22.9 million, or $0.28 loss per diluted share, in Q2 FY16. Meanwhile, the Company's adjusted net income grew to $129.1 million, or $1.51 per diluted share, during Q2 FY17 from $111.2 million, or $1.29 per diluted share, in the previous year's same quarter. Wall Street had expected the Company to report adjusted net income of $1.10 per diluted share.Operational MetricsFor the reported quarter, the Company's cost of sales was $218.8 million, lower than the $236.3 million reported in Q2 FY16. The Company's gross profit came in at $928.1 million for Q2 FY17 compared to $965.5 million in the prior year's corresponding quarter. The Company's GAAP gross margin stood at 80.9% for Q2 FY17 versus 80.3% in Q2 FY16. Selling, general, and administrative expenses (SG&A) was $443.2 million in Q2 FY17 compared to $676.8 million in Q2 FY16. The Company posted operating income of $204.9 million in Q2 FY17 compared to operating loss of $19.9 million in Q2 FY16.Geographical RevenuesIn Q2 FY17, Herbalife' revenues from North America fell to $218.4 million from $266.5 million in Q2 FY16. Mexico region's revenue contribution came in at $115.6 million for Q2 FY17 compared to $119.3 million in Q2 FY16. Revenues from South and Central America declined to $110.0 million in Q2 FY17 from $119.9 million in the last year's comparable quarter. Meanwhile, the revenues from EMEA region increased to $224.7 million during the reported quarter from $219.0 million in Q2 FY16. Herbalife' revenues from Asia/Pacific region increased marginally to $235.5 million in Q2 FY17 from $234.6 million in Q2 FY16. Furthermore, revenues contribution from China was $242.7 million for Q2 FY17 compared to $242.5 million in Q2 FY16.Cash Flow & Balance SheetDuring first six months of FY17, Herbalife's net cash provided by operating activities were $277.1 million compared to $368.0 million in the year ago comparable quarter. At the close of books in the reported quarter, Herbalife had $1.62 billion in cash and cash equivalents as on June 30, 2017, compared to $844.0 million at the close of books on December 31, 2016. Furthermore, long-term debt balance as on June 30, 2017, stood at $2.19 billion compared to $1.44 billion as on December 31, 2016.Share RepurchaseSince the inception of share repurchase program in February 2017, the Company has repurchased, a total of approximately 4.6 million shares with approximately 2.5 million shares repurchased during the period of May 01, 2017, through July 31, 2017OutlookThe Company raised its reported EPS guidance for full-year FY17 to a range of $3.80 to $4.20 up from the previous ranges of $3.30 to $3.70. The adjusted diluted EPS outlook for FY17 is now projected to be in the range of $4.30 to $4.70 from the prior guidance range of $4.10 to $4.50.In its outlook for Q3 FY17, the Company projects diluted EPS in the range of $0.48 to $0.68, while adjusted diluted EPS is expected to be in the range of $0.65 to $0.85.Stock PerformanceAt the closing bell, on Wednesday, August 16, 2017, Herbalife's stock climbed 1.09%, ending the trading session at $63.13. A total volume of 1.47 million shares have exchanged hands, which was higher than the 3-month average volume of 1.07 million shares. The Company's stock price advanced 2.27% in the past six months. Moreover, the stock surged 31.14% since the start of the year. The stock is trading at a PE ratio of 13.25 and currently, has a market cap of $5.89 billion.Pro-Trader Daily:Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.PRESS RELEASE PROCEDURES:The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected] Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.NO WARRANTYPRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.NOT AN OFFERINGThis document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:Email: [email protected] number: (917) 341.4653Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.SOURCE: Pro-Trader DailyReleaseID: 472890

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Rod R. Little's photo - President & CEO of Edgewell

President & CEO

Rod R. Little

CEO Approval Rating


Edgewell manufactures and commercializes cosmetic, personal and health care products for men and women. Read more